Work

Generating evidence for therapeutic effects: the need for well-conducted randomized trials

Year: 2020

Type: article

Abstract: In this viewpoint, Robert Califf, former commissioner of the U.S. Food and Drug Administration, and colleagues reflect on how to approach questions about which patient treatments and strategies work, particularly in light of the tremendous pressure on the government and biomedical research enterprise to quickly develop safe, effective therapies during the SARS-CoV-2 pandemic.

Source: Journal of Clinical Investigation

DOI: 10.1172/jci146391

Authors: Robert M. Califf, Lesley H. Curtis, Robert A. Harrington, Adrian F. Hernandez, Eric D. Peterson

Institutions: Duke University, Stanford Medicine, Verily Life Sciences LLC (United States), Stanford University, The University of Texas Southwestern Medical Center

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3110463647

FWCI: 1.036

Cites: 11

Cited by: 7

Related to: 10